Sajesh, B.V.; On, N.H.; Omar, R.; Alrushaid, S.; Kopec, B.M.; Wang, W.-G.; Sun, H.-D.; Lillico, R.; Lakowski, T.M.; Siahaan, T.J.;
et al. Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors. Pharmaceutics 2019, 11, 481.
https://doi.org/10.3390/pharmaceutics11090481
AMA Style
Sajesh BV, On NH, Omar R, Alrushaid S, Kopec BM, Wang W-G, Sun H-D, Lillico R, Lakowski TM, Siahaan TJ,
et al. Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors. Pharmaceutics. 2019; 11(9):481.
https://doi.org/10.3390/pharmaceutics11090481
Chicago/Turabian Style
Sajesh, Babu V., Ngoc H. On, Refaat Omar, Samaa Alrushaid, Brian M. Kopec, Wei-Guang Wang, Han-Dong Sun, Ryan Lillico, Ted M. Lakowski, Teruna J. Siahaan,
and et al. 2019. "Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors" Pharmaceutics 11, no. 9: 481.
https://doi.org/10.3390/pharmaceutics11090481
APA Style
Sajesh, B. V., On, N. H., Omar, R., Alrushaid, S., Kopec, B. M., Wang, W.-G., Sun, H.-D., Lillico, R., Lakowski, T. M., Siahaan, T. J., Davies, N. M., Puno, P.-T., Vanan, M. I., & Miller, D. W.
(2019). Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors. Pharmaceutics, 11(9), 481.
https://doi.org/10.3390/pharmaceutics11090481